Semaglutide Has emerged as a groundbreaking medication, transforming the landscape of healthcare for those with type 2 diabetes, obesity, and cardiovascular risk factors. Initially developed for diabetes management, semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the natural hormone GLP-1 (glucagon-like peptide-1). This hormone https://sethvzcgj.blogrenanda.com/37032450/semaglutide-revolutionizing-the-treatment-of-obesity-type-2-diabetes-and-heart-health